Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 10.97 is 29% above its 5-year average of 8.52, near the low end of its 5-year range (2.61–41.70).
As of the fiscal period ended Tuesday, June 30, 2026. 4.04% above its 12-month average of 10.54.
Reported quarterly quick ratio; no daily interpolation. Q1 FY2027 (2026-06-30): 10.97.
QUICK RATIO (ACID-TEST)
10.97
QUICK RATIO (ACID-TEST) AVG TTM
10.54
QUICK RATIO (ACID-TEST) AVG 3Y
9.63
QUICK RATIO (ACID-TEST) AVG 5Y
8.52
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+4.04%
CURRENT VS 3Y AVG
+13.85%
CURRENT VS 5Y AVG
+28.78%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.19
median of 736 covered companies
CURRENT VS SECTOR MEDIAN
+243.84%
vs the sector median at left
Helus Pharma Inc.
Market Cap
$681.21M
Quick Ratio (Acid-Test)
10.97
TTM Avg
10.54
3Y Avg
9.63
5Y Avg
8.52
Market Cap
$681.58M
Quick Ratio (Acid-Test)
5.53
TTM Avg
8.02
3Y Avg
10.47
5Y Avg
14.43
Market Cap
$672.27M
Quick Ratio (Acid-Test)
8.03
TTM Avg
12.16
3Y Avg
13.50
5Y Avg
14.42
Market Cap
$690.28M
Quick Ratio (Acid-Test)
14.20
TTM Avg
2.59
3Y Avg
2.42
5Y Avg
2.06
Market Cap
$670.50M
Quick Ratio (Acid-Test)
4.79
TTM Avg
3.80
3Y Avg
3.38
5Y Avg
3.21
Market Cap
$659.73M
Quick Ratio (Acid-Test)
14.16
TTM Avg
12.98
3Y Avg
15.39
5Y Avg
17.04
Market Cap
$713.86M
Quick Ratio (Acid-Test)
8.86
TTM Avg
10.22
3Y Avg
11.35
5Y Avg
25.38
Market Cap
$717.52M
Quick Ratio (Acid-Test)
19.31
TTM Avg
14.05
3Y Avg
7.67
5Y Avg
5.91
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Helus Pharma Inc. (HELP) | $681.21M | 10.97 | 10.54 | 9.63 | 8.52 |
| Annexon, Inc. (ANNX)vs › | $681.58M | 5.53 | 8.02 | 10.47 | 14.43 |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $672.27M | 8.03 | 12.16 | 13.50 | 14.42 |
| Anteris Technologies Global Corp. (AVR)vs › | $690.28M | 14.20 | 2.59 | 2.42 | 2.06 |
| MiMedx Group, Inc. (MDXG)vs › | $670.50M | 4.79 | 3.80 | 3.38 | 3.21 |
| ArriVent BioPharma, Inc. (AVBP)vs › | $659.73M | 14.16 | 12.98 | 15.39 | 17.04 |
| OmniAb, Inc. (OABI)vs › | $654.55M | 4.80 | 4.27 | 4.36 | 3.29 |
| Olema Pharmaceuticals, Inc. (OLMA)vs › | $713.86M | 8.86 | 10.22 | 11.35 | 25.38 |
| Avalo Therapeutics, Inc. (AVTX)vs › | $717.52M | 19.31 | 14.05 | 7.67 | 5.91 |
| Collegium Pharmaceutical, Inc. (COLL)vs › | $718.54M | 0.84 | 1.18 | 1.08 | 1.08 |
Quick Ratio
10.97
Excludes inventory
Current Ratio
10.97
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 10.97 |
| 2026-03-31 | 9.52 |
| 2025-12-31 | 13.78 |
| 2025-09-30 | 8.58 |
| 2025-06-30 | 9.87 |
| 2025-03-31 | 7.75 |
| 2024-12-31 | 12.60 |
| 2024-09-30 | 24.24 |
| 2024-06-30 | 41.70 |
| 2024-03-31 | 21.65 |
| 2023-12-31 | 5.76 |
| 2023-09-30 | 2.89 |
| 2023-06-30 | 2.61 |
| 2023-03-31 | 4.09 |
| 2022-12-31 | 6.89 |
| 2022-09-30 | 7.84 |
| 2022-06-30 | 7.52 |
| 2022-03-31 | 7.38 |
| 2021-12-31 | 11.40 |
| 2021-09-30 | 13.92 |
| 2021-06-30 | 9.93 |
| 2021-03-31 | 13.57 |
| 2020-12-31 | 8.56 |
| 2020-10-31 | 4.70 |
| 2020-06-30 | 3.67 |
| 2019-12-31 | 0.00 |
| 2019-07-31 | 0.00 |
| 2019-04-30 | 0.00 |
| 2019-01-31 | 43.70 |
| 2018-10-31 | 0.00 |
| 2018-07-31 | 27.38 |
| 2018-04-30 | 0.00 |
| 2018-01-31 | 371.70 |
| 2017-10-31 | 16.78 |
